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Background: Interest in the welfare and diseases of donkeys is constantly increasing in several countries. Despite
this, clinical research into donkeys needs to be in continual development since they show different reactions
compared to horses in many conditions, including infectious diseases, and need specific clinical and therapeutic
approaches. No reports are currently available on clinical and clinical pathology data regarding donkeys with
natural piroplasms infection.
Results: Venous blood samples were taken from one hundred and thirty eight donkeys and underwent indirect
fluorescent antibody test (IFAT) to detect IgG antibodies against Theileria equi and Babesia caballi and real-time
polimerase chain reaction (PCR) to detect Babesia spp. and Theileria spp. Clinical examinations, haematological
analyses and serum bilirubin evaluation were also performed and compared with positive or negative status.
A seroprevalence of 40.6% and 47.8% was found for T. equi and B. caballi, respectively; double positivity was
detected in 19.6% of the animals. PCR results showed that 17.4% of the animals tested positive for T.equi and
3.6% for B. caballi with no double positivity. Twelve donkeys (8.7%) had clinical signs consistent with chronic forms
of the disease and no acute forms were detected. Fifty-eight donkeys had haematological and serum bilirubin
alterations and 56 (96.6%) of them were IFAT and/or PCR positive. Changes in erythrocyte number, packed cell
volume, hemoglobin concentration, mean corpuscular hemoglobin, platelets number and total bilirubin were
significantly associated with positive and symptomatic animals.
Conclusion: Nonspecific clinical presentation seems to be very common in donkeys and several clinical pathology
alterations persist after natural infection. Therefore, apparently healthy donkeys can have masked but severe clinical
pathology alterations. Acute forms are very seldom observed in donkeys. Clinical monitoring of chronically infected
donkeys is recommended since such animals represent a risk both for transmission to other animals and for their
own health; furthermore, their production performances could be reduced. The study should also be intended as a
contribution for veterinary practitioners because it describes the most usual clinical presentations and laboratory
findings of equine piroplasmosis in naturally infected donkeys in endemic areas.
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Interest in the welfare and diseases of donkeys is con-
stantly increasing in several countries, mostly due to the
recent rediscovery of donkey milk as an alternative food
source for milk-intolerant children. Clinical research on
donkeys needs to be in continual development since
they have different reactions compared to horses in* Correspondence: fulvio.laus@unicam.it
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unless otherwise stated.many conditions (e.g. resistance to pain in case of colic),
including infectious diseases, making it more difficult to
recognize the symptoms normally observed in horses
[1,2]. Their current popularity is also due to their use as
pets, in addition to recreational purposes, sports activ-
ities, donkey-assisted therapy and, to a lesser extent, as
pack/draught animals and for meat production [3].
Equine piroplasmosis (EP) is a tickborne disease
caused by the protozoa Babesia caballi and Theileria
equi. EP is endemic in most equine populations in trop-
ical and subtropical areas of the world and affects allis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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bras [4,5]. Chronic cases are more common in donkeys
than horses and are usually characterized by nonspecific
clinical signs such as lethargy, partial anorexia, poor
work performance and body weight loss [6]. In acute
forms of EP, donkeys can show fever, listlessness,
depression, noticeable thirst, swelling of the eyelids, con-
stipation, presence of yellow mucous covering feces,
yellowish coloration of urine, and splenomegaly [6].
Donkeys can also show an asymptomatic form of the in-
fection and, in comparison to horses, they also show a
lower parasitemia [6]. The most common hematological
alteration found in horses is decreased packed cell
volume, hemoglobin and erythrocyte number, in addition
to hyperbilirubinemia and thrombocytopenia [3]. After
subclinical, chronic or acute infection, donkeys usually re-
main asymptomatic carriers with positive antibody titers
throughout life [6].
Several data are available for the epidemiology of
equine piroplasmosis (EP) in horses [7,8] and informa-
tion on its epidemiology in Italy has also been reported
[9-13]. However, few reports exist regarding the preva-
lence of these parasites in donkeys [14-17] and, to the
authors’ knowledge, only few surveys have been carried
out in Italy [18-20]. The present study is the first investi-
gation aimed at evaluating and comparing the direct (by
PCR) and indirect (by IFAT) presence of B. caballi and
T. equi with clinical signs and clinical pathology data in
naturally infected donkeys in Italy.
Methods
One hundred and thirty eight mixed breed donkeys (109
females, 7 stallions and 22 geldings) ranging from 1 to
22 years of age (mean 7.6, d.s. = 4.7) belonging to 8 dif-
ferent farms (mean herd size 17 donkeys, d.s. 6 donkeys)
in central Italy were included in the study. The area was
chosen due to the high prevalence of tickborne patho-
gens previously found in equids [12,13,18,21,22], the
proven presence of the tick vectors [23] and because vet
practitioners have frequently reported heavy tick infesta-
tions in equids. All the animals were born and reared in
Italy and had never been moved out of the country. The
survey was performed between March and October 2013
in farms of varying nature and size, including herds for
milk production (n = 5), onotherapy centers (n = 2) and
private facilities (n = 1) where animals were reared for
leisure. De-worming and topical ectoparasite repellents
were regularly administered to all the animals who were
free from ticks at the moment of evaluation.
A general clinical examination was performed on each
donkey; the evaluation also included a body condition
score (BCS) estimation, following the scheme of Pearson
and Quassat (1996) [24]. Donkeys showing clinical signs
not attributable to EP (e.g. lameness) were excludedfrom the study to avoid interference on blood analysis.
Venous blood samples were collected from each donkey
from the jugular vein into sterile tubes with (two tubes)
and without (one tube) ethylenediaminetetraacetic acid
(EDTA) and maintained at +4°C. The samples with
EDTA were submitted for a complete blood count
(CBC), which included: erythrocytes count (RGB), packed
cell volume (PCV), hemoglobin (Hb), mean corpuscular
volume (MCV), mean corpuscular hemoglobin (MCH),
mean corpuscular hemoglobin concentration (MCHC),
total leukocytes, neutrophils, lymphocytes, monocytes, eo-
sinophils, basophils and platelets (Cell Dyn 3500, Abbott).
Moreover, an aliquot of 200 μl was destined to genomic
DNA extraction using the QIAamp DNA Blood Mini kit
(QIAGEN S.p.A., Milan, Italy) according to the manufac-
turer’s instructions. To ensure the effectiveness of the nu-
cleic acid extraction, a PCR targeting the 18S rRNA was
applied [25]. The extracted DNA was submitted to a Real
Time PCR Sybr Green assay to detect 509 base pairs of 18S
rRNA gene of Babesia spp. and Theileria spp. using the pri-
mer BJ1 and BN2 described by Casati et al. (2006) [26].
The method shows a sensitivity of 10^3 DNA copies/μl.
The species identity was determined by subsequent ampli-
con sequencing. All PCR products were sequenced using
the Big Dye Terminator v 3.1 cycle sequencing kit (Applied
Biosystem, Foster City, CA, USA) in a 16-capillary ABI
PRISM 3130 × l Genetic Analyzer (Applied Biosystem,
Foster City, CA, USA). Sequence data were assembled and
edited with SeqScape software v 2.5 (Applied Biosystem,
Foster City, CA, USA), aligned and compared with repre-
sentative sequences available in GenBank [27].
Samples without EDTA were centrifuged at 4000 rpm
for 10 minutes; the separated sera were collected and di-
vided into two aliquots. The first aliquot was used for
dosage of total bilirubin (TB) (Targa 3000 plus, Biotec-
nica Instruments); the second was utilized to determine
the presence of IgG antibodies against T. equi and B.
caballi using a commercial indirect fluorescent antibody
test (IFAT) (MegaScreen®, 112 DIAGNOSTIK MEGA-
CORE Laboratories, Horbranz, Austria).
Statistical analysis
Prevalence and 95% binomial confidence intervals (CI)
were calculated [28] for the serologic and molecular test
results.
Hematological parameters and serum bilirubin were
tested for normality by Kolmogorof-Smirnov test and
then analyzed by ANOVA or Mann–Whitney U-test for
comparison between positive (both to PCR and/or IFAT)
and negative animals and between donkeys with and
without clinical signs. Comparison of the clinical path-
ology results with normal reference values [29] was car-
ried out using a t-student’s test. The Chi-square test was
performed to evaluate the differences between IFAT and
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nificance was assessed at the 0.05 probability level in all
analyses.
All statistical analyses were performed using the WIN-
PEPI (PEPI-for-Windows) computer program (Epidemiol.
Perspect. Innov. 1:6. Available from: http://www.biomed-
central.com/1742-5573/1/6).
Ethical statement
Tha autor state that the work has been carried out in
compliance with relevant guidelines regarding ethical
use of animals, approved by the Universitary Ethical
Commettee for Animal Protection and in adherence to a
high standard (best practice) of veterinary care.
Results
Ninety-five (68.8%) and 29 (21.0%) donkeys tested posi-
tive by IFAT and PCR respectively. The results of the
serological and molecular tests performed on blood sam-
ples are reported in Table 1, as well as the prevalence
(%) and 95% confidence interval (CI) of single and
mixed-infections.
All herds (100%) resulted positive at IFAT for both T.
equi and B. caballi and at PCR for T. equi. Three herds
(37.5%) resulted positive for B. caballi at PCR. The
prevalence rates within herd are reported in Table 2.
The seroprevalence of B. caballi resulted higher than
that of T. equi but the difference was not statistically
significant (P = 0.3). The percentage of PCR positive
animals resulted statistically higher for T. equi than B.
caballi (P < 0.001).
Nine (6.5%, 95% CI: 3.0-12.90%) animals were simul-
taneously IFAT and PCR positive for T. equi while 15
(10.9%, 95% CI: 6.2-17.30%) were only PCR positive.
None of the IFAT positive donkeys resulted PCR positive
for B. caballi.
Abnormal clinical pathology data with respect to nor-
mal ranges were detected in 58 (42.0%) samples. Fifty-
six (96.6%) of these donkeys resulted IFAT and/or PCR
positive. Hematological alterations included decreasedTable 1 Number of donkeys, prevalence and confidence inter
serological and molecular testing
IFAT
Pathogens No. of positive samples (n = 138) Prevalence (9
T. equi 56 40.6% (32.3-49
B. caballi 66 47.8% (39.3-56
Single infection
T. equi 29 21.0% (14.6-28
B. caballi 39 28.3% (20.9-36
Double infection
T. equi + B. caballi 27 19.6% (13.3-27
IFAT, indirect fluorescent antibody test; PCR, Polymerase Chain Reaction; CI, confideRGB (n = 49), decreased PCV (n = 24), decreased Hb (n
= 31), increased MCH (n = 16), increased MCHC (n = 9)
increased WBC (n = 6), increased neutrophils (n = 7), in-
creased eosinophils (n = 5), decreased platelets (n = 20),
and increased bilirubin (n = 19). Among IFAT positive
donkeys, 46 (48.4%) had one or more hematological
and/or bilirubin alteration: 18 (39.1%) proved positive
for B.caballi, 18 (39.1%) for T. equi and 10 (21.7%) were
double positives. Among PCR positive donkeys, 19
(65.5%) had one or more hematological and/or bilirubin
alteration: 1 (5.3%) was positive for B. caballi and 18
(94.7%) were positive for T. equi. The statistical differ-
ences between positive (both to PCR and/or IFAT) and
negative animals are reported in Table 3.
Twelve (10.4%) of the positive donkeys presented signs
related to chronic piroplasm infection at the moment of
evaluation and all of them were positive for at least one
test (Table 4). Detected clinical signs included mild
depression (n = 11), body condition score ≤ 2 (n = 10), in-
appetence (n = 10), pale mucous membranes (n = 4) and
mild icterus (n = 6). MCH, MCHC, and TB were statisti-
cally higher in symptomatic than in negative donkeys
while RGB, PCV, Hb, and platelets were lower. When
the blood parameters of symptomatic donkeys were
compared to asymptomatic/positives, Hb, MCH and TB
resulted in being the only statistically different parame-
ters (P = 0.001, P = 0.0005 and P = 0.005, respectively).
Discussion
Although not statistically significant, the seroprevalence
of B. caballi (47.8%) was higher than that of T. equi
(40.6%) in accordance with the results obtained in don-
keys in Italy [18-20] or in other countries [14,16,17].
The percentage of PCR positive animals resulted statisti-
cally higher for T. equi (17.4%) than B. caballi (3.6%)
proving that also in donkeys T. equi can persist in a sub-
clinical form for longer than B. caballi [30].
In general, the chronic and subclinical natural infec-
tion in donkeys included in this study seems to be asso-
ciated with decreased RGB, PCV, Hb and PLT and withval of the equine tick-borne infections investigated using
PCR
5% CI) No. of positive samples (n = 138) Prevalence (95% CI)
.3) 24 17.4% (11.5-24.4)
.5) 5 3.6% (1.2-8.3)
.8) 24 17.4% (10.3-23.1)
.6) 5 3.6% (0.5-6.2)
.2) 0 0
nce interval.
Table 2 Intra-herd prevalence of Babesia caballi and Theileria equi
Herd Number of donkeys IFAT prevalence B. caballi PCR prevalence B. caballi IFAT prevalence T. equi PCR prevalence T. equi
1 24 58,3% 8,3% 45,8% 12,5%
2 15 40,0% 0,0% 20,0% 13,3%
3 8 37,5% 0,0% 25,0% 12,5%
4 17 52,9% 0,0% 47,1% 29,4%
5 14 64,3% 14,3% 50,0% 28,6%
6 19 47,4% 0,0% 42,1% 21,1%
7 27 44,4% 0,0% 40,7% 14,8%
8 14 28,6% 7,1% 42,9% 7,1%
IFAT, indirect fluorescent antibody test; PCR, Polymerase Chain Reaction.
Table 3 Mean, standard deviation and statistical association with negative donkeys of hematobiochemical
paramethers
Negative IFAT positive PCR positive PCR and IFAT positive










T. equi mean (sd)
RGB (106/μl) 6.7 (0.8) 5.1 (0.8) 5.0 (0.9) 5.1 (1.0) 5.9 (1.1) 4.7 (0.8) 4.1 (0.4)
P < 0.001 P < 0.001 P < 0.001 P = 0.1 P < 0.001 P < 0.001
PCV % 35 (5) 32 (4) 32 (5) 31 (7) 33 (2) 29 (3) 31 (6)
P = 0.004 P = 0.06 P = 0.02 P = 0.3 P < 0.001 P = 0.02
Hb (g/dl) 12.1 (1.3) 10.7 (1.4) 10.5 (2.4) 10.4 (2.2) 10.9 (1.1) 9.1 (1.4) 7.9 (0.9)
P < 0.001 P = 0.007 P = 0.002 P = 0.06 P < 0.001 P < 0.001
MCV (fl) 52.5 (3.8) 55.1 (3.5) 54.0 (8.0) 56.0 (3.8) 51.3 (4.3) 54.2 (3.1) 55.6 (4.2)
P = 0.7 P = 0.6 P = 0.3 P = 0.5 P = 0.5 P = 0.3
MCH (pg) 19.1 (1.5) 20.7 (2.0) 20.3 (1.4) 21.0 (2.0) 19.0 (1.7) 23.7 (4.3) 22.3 (1.8)
P = 0.002 P = 0.01 P < 0.001 P = 0.9 P < 0.001 P < 0.001
MCHC (g/dl) 34.2 (1.5) 35.0 (1.7) 34.9 (1.4) 35.2 (2.2) 35.3 (1.9) 34.9 (1.5) 36.1 (2.0)
P = 0.06 P = 0.1 P = 0.07 P = 0.2 P = 0.2 P = 0.006
WBC (103/μl) 8.9 (2.9) 9.1 (2.7) 10.1 (2.6) 8.9 (2.4) 9.9 (2.9) 8.7 (2.3) 9.9 (1.7)
P = 0.8 P = 0.2 P = 0.9 P = 0.5 P = 0.8 P = 0.3
Neutrophils (103/μl) 5.1 (2.4) 4.3 (1.7) 4.4 (0.9) 4.3 (1.9) 5.2 (1.7) 4.8 (1.6) 6.5 (2.9)
P = 0.4 P = 0.6 P = 0.3) P = 0.3 P = 0.3 P = 0.007
Lymphocytes (103/μl) 4.6 (1.9) 4.8 (1.9) 5.4 (2.1) 5.2 (1.9) 5.4 (1.7) 5.6 (1.6) 5.9 (0.9)
P = 0.6 P = 0.2 P = 0.4 P = 0.3 P = 0.1 P = 0.06
Monocytes (103/μl) 0.2 (0.2) 0.2 (0.2) 0.3 (0.2) 0.2 (0.2) 0.0 (0.1) 0.3 (0.2) 0.1 (0.2)
P = 0.6 P = 0.05 P = 0.3 P = 0.1 P = 0.1 P = 0.9
Eosinophils (103/μl) 0.4 (0.3) 0.5 (0.4) 0.4 (0.3) 0.6 (0.4) 0.5 (0.3) 0.6 (0.4) 0.6 (0.5)
P = 0.3 P = 0.4 P = 0.09 P = 0.1 P = 0.1 P = 0.07
Basophils (103/μl) 0.1 (0.1) 0.0 (0.1) 0.1 (0.1) 0.1 (0.0) 0.1 (0.0) 0.1 (0.1) 0.0 (0.1)
P = 0.3 P = 0.7 P = 0.3 P = 0.07 P = 0.9 P = 0.6
Platelets (103/μl) 326 (65) 277 (102) 267 (83) 209 (77) 229 (67) 254 (63) 271 (79)
P = 0.04 P = 0.01 P < 0.001 P = 0.006 P = 0.002 P = 0.05
TB (mg/dl) 0.3 (0.1) 0.3 (0.14) 0.1 (0.2) 0.3 (0.2) 0.2 (0.0) 0.5 (0.3) 0.3 (0.1)
P = 0.3 P = 0.6 P = 0.3 P = 0.2 P = 0.005 P = 0.3
IFAT, indirect fluorescent antibody test; PCR, Polymerase Chain Reaction; RGB, erythrocytes; PCV, packed cell volume; Hb, hemoglobin; MCV, mean corpuscular
volume; MCH, mean corpuscular hemoglobin, MCHC, mean corpuscular hemoglobin concentration; WBC, white blood cell; PLT, platelet; TB, total bilirubin.
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Table 4 IFAT/PCR positivity and changed hematology and serum bilirubin in symptomatic donkeys
Donkeys Positivity Clinical signs Clinical pathology
1 Double IFAT Depression ↓RGB, ↓Hb, ↓PCV, ↑MCH, ↑MCHC, ↑Neutrophils, ↑Eosinophils
BCS <2
Inappetence




3 Double IFAT Depression ↓RGB, ↓Hb, ↓PCV, ↓PLT
BCS <2
Inappetence












7 Double IFAT Depression ↓RGB, ↓Hb, ↓PLT, ↑TB
BCS <2
Inappetence
8 PCR T.equi Depression ↓RGB, ↓Hb, ↓PCV, ↑MCH, ↑MCHC, ↑TB
BCS <2
Inappetence
9 PCR T.equi Depression ↓RGB, ↓Hb, ↓PCV, ↓PLT, ↑TB
Pale MM









12 PCR and IFAT (T. equi) Pale MM ↓RGB, ↓Hb, ↑TB
Icterus
IFAT, indirect fluorescent antibody test; PCR, Polymerase Chain Reaction; RGB, erythrocytes; Hb, hemoglobin; PCV, packed cell volume; WBC, white blood cell; PLT,
platelet; TB, total bilirubin; MCH, mean corpuscular hemoglobin, MCHC,mean corpuscular hemoglobin concentration, MM mucous membranes.
↑, higher than normal; ↓, lower than normal.
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studies carried out on donkeys is not reliable since they
are experimental trials aimed at investigating pathogenic
mechanisms or the efficacy of drugs or vaccines often
on few splenectomised donkeys [31-36].
Almost all the donkeys having one or more hematological
disorder resulted IFAT positive for B. caballi and/or T. equi;
the only two negative animals had increased WBC, neutro-
phils or eosinophils but similar alterations are not usually
related to piroplasm chronic infections [37]. These findings
are of remarkable importance since these animals (repre-
senting almost half of the IFAT positive donkeys), could
not have cleared the parasites from their blood after natural
infection, but could only have reduced the level beyond the
sensitivity of the PCR test [16]. This consideration is also
supported by the fact that 8 (66.7%) of the 12 symptomatic
donkeys were IFAT but not PCR positive. Most of the alter-
ations were related to hematological signs of anaemia,
thrombocytopenia and hemolysis, could suggest the pres-
ence of a direct and immune-mediated pathogenic activity
of the parasites.. As a consequence of this kind of subclin-
ical infection, the donkeys could have a reduction of their
work or production performance, although further specific
investigation are needed to verify such occurrence. A simi-
lar situation can also occur in horses, in which slight
anemia caused by chronic infection can result in poor ath-
letic performances [3]. However, because of the naturally
more quiet behavior of donkeys, their resistance to diseases
and the more rural type of farming, in this species it could
be difficult to recognize some subtle nonspecific alteration
(e.g. reduced milk production, slight decrease in work activ-
ity) without a careful evaluation. Piroplasmosis should be
considered a differential diagnosis in these animals, which
should therefore be monitored for risk of stress (e.g. heavy
work load, separation from the foal for the lactating jenny).
Furthermore, these animals should also be considered po-
tential asymptomatic carriers.
T. equi infected donkeys (e.g. PCR positives) showed a
higher likelihood of having hematological alterations
compared with B. caballi infected animals. The only
alteration found in donkeys proving positive for B.
caballi was a decrease in PLT in one subject. This is in
contrast with findings reported for horses, where
anemia, thrombocytopenia and leukopenia are reported
to have a high incidence also in B. caballi positive sub-
jects [38]: the low number of positive animals (n = 5) in
the present and in the cited paper could have influenced
such statistical results. However, none of the B. caballi
infected donkeys showed clinical symptoms and it is pos-
sible to speculate that T. equi has a higher pathogenicity
than B. caballi in donkeys as suggested for horses [16].
T. equi infected donkeys also have a higher TB serum
level compared both to negative and to other positive
donkeys. The recent infection causing hemolytic anemiacould be the reason for this condition since donkeys simul-
taneously PCR and IFAT positive which are supposed to
have a less recent infection since they have already devel-
oped antibodies, showed no such association.
Neutrophilia was found to be related only to PCR/
IFAT positive to T. equi (P = 0.006). Acute experimental
infection in donkeys can be characterized by a high ab-
solute neutrophil count [6] but, although these donkeys
resulted to be infected, none of them showed signs of
the acute form of the disease. More investigations are
needed to confirm if similar alterations of white blood
cells relate to natural piroplasm infection or are due to
concomitant subclinical diseases as we suppose.
In the present study, only Hb, MCHC and TB resulted
to be statistically different between symptomatic and
non-symptomatic animals. It could be possible to specu-
late that donkeys can control the clinical symptoms after
natural infection in endemic areas, but, at the same time,
they can have some residual hematochemical alterations
similar to those of symptomatic animals, exposing them
to the risk of disease or poor performance.
It should also be highlighted that 19 of the 24 donkeys
who resulted PCR positive for T. equi were found to be
free from clinical signs. These animals confirm that sub-
clinical forms are widespread among donkeys reared in
endemic areas, as observed in horses [13] Such findings
also support the existence of lifelong carriers, which are
persistently infected subjects, potentially capable of en-
hancing the spread of these pathogens.
Conclusions
The high prevalence of piroplasms and associated hema-
tochemical alterations in non-symptomatic donkeys or
in donkeys with minimal clinical evidence found in this
study could be more usual than previously considered,
especially in areas where piroplasmosis is endemic. Such
animals should be monitored for red cells, red cell re-
lated parameters and thrombocytopenia because un-
apparent carriers can occasionally exhibit relapses of the
clinical disease associated with stress, strenuous exercise,
immunosuppression, and steroid administration. Further-
more, these animals can act as a source of piroplasms for
ticks, increasing the probability of transmission to other an-
imals, including horses. Since the effects of this unapparent
infection and its possible consequences on the production
performance of the donkeys (milk quantity and quality,
weight gain, work performance) are not yet known, further
studies to investigate such relationships should be per-
formed. Currently there is no suitable pharmacotherapy
available to clear the T. equi infection from affected don-
keys [6]. It has therefore become urgent to act with surveil-
lance plans and preventive therapy. The study should also
be intended as a contribution for veterinary practitioners
because it describes the most usual clinical presentations
Laus et al. BMC Veterinary Research  (2015) 11:100 Page 7 of 7and laboratory findings of EP in naturally infected donkeys
in Italian endemic areas.
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